Advocacy intelligence hub — real-time data for patient organizations
PT. Prodia Stem Cell Indonesia — PHASE1, PHASE2
Jiangsu Hansoh Pharmaceutical Co., Ltd. — PHASE2
AstraZeneca — PHASE2
Anasonic — NA
MediBeacon — NA
Novartis Pharmaceuticals — PHASE3
Assistance Publique - Hôpitaux de Paris — NA
Luo Yaping — NA
Enyo Pharma — PHASE2
Shanghai Changzheng Hospital — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Mårten Segelmark, MD PhD Prof
Linkoeping University
Dana V Rizk, M.D
University of Alabama Birmingham, 205-934-9509, drizk@uab.edu
Tevfik Ecder, Professor
Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Nephrology
Meryl A Waldman, M.D., M.D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 BETHESDA, MD
Yasar Caliskan, MD, MD
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
📍 NASHVILLE, TN
Julien ALLARD, MD
University Hospital, Limoges